Expertise: Biomarkers, Cancer Interception, Disease Area Strongholds, Tumor Microenvironment
Wayne Rackoff, M.D. is Vice President, Clinical Oncology at Janssen Research & Development, LLC. His primary responsibilities include directing a project in conjunction with the Tufts Center for the Study of Drug Development in Massachusetts to develop a decision-making algorithm for advancing drugs from Phase 2 to Phase 3 in clinical development, modeling and implementing new approaches to patient accrual that will hasten the completion of late-stage oncology studies, and leading the clinical activities on major licensing and acquisition projects.
While at Janssen Research & Development, Wayne has worked as a Medical Affairs Physician, and as a Project Physician, Clinical Team Leader and Head of the Clinical Group in Oncology Research & Development.
Prior to joining Janssen Research & Development, Wayne served as a faculty member of the Indiana University School of Medicine in Indianapolis, and in a public hospital-based pediatric hematology-oncology practice in South Florida. He was also the Vice President of Early Development Oncology at GlaxoSmithKline.
Wayne holds a bachelor’s degree in English from Emory University, Atlanta, Georgia, and a master’s in political science and a medical degree from The University of North Carolina at Chapel Hill, where he completed his residency training in Pediatrics. He was a fellow in pediatric hematology-oncology at The Children’s Hospital of Philadelphia, Pennsylvania.